Source:http://linkedlifedata.com/resource/pubmed/id/19001020
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
22
|
pubmed:dateCreated |
2008-11-25
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1524-4539
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
25
|
pubmed:volume |
118
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2223-4
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19001020-Amlodipine,
pubmed-meshheading:19001020-Calcium Channel Blockers,
pubmed-meshheading:19001020-Heart Failure,
pubmed-meshheading:19001020-Humans,
pubmed-meshheading:19001020-Hypertension,
pubmed-meshheading:19001020-Hypolipidemic Agents,
pubmed-meshheading:19001020-Myocardial Infarction,
pubmed-meshheading:19001020-Stroke Volume
|
pubmed:year |
2008
|
pubmed:articleTitle |
Hypertension, heart failure, and ejection fraction.
|
pubmed:publicationType |
Editorial,
Comment
|